Literature DB >> 8539453

Radiation induced G1-block and p53 status in six human cell lines.

F Zölzer1, S Hillebrandt, C Streffer.   

Abstract

Considerable attention has recently been focused on the fact that the tumor suppressor protein p53 is involved in the cellular response to radiation. In its wild-type form the protein appears to control a cell cycle checkpoint, preventing entry into S-phase following DNA damage. A number of authors observed a radiation induced G1-block in cells expressing wild-type p53, but not in p53 mutant cells. We obtained similar results with four human tumour cell lines as well as two strains of human fibroblasts, whose p53 status was ascertained at the protein as well as DNA levels. In addition to cell cycle delays in exponentially growing cell cultures, we have studied the possible role of the p53 in the transition from quiescence to active proliferation. Cells were irradiated after 6 days of serum-starvation and labelled with BrdU at different times after addition of fresh medium. Entry into S-phase was found to be delayed by several hours in the p53 wild-type cells, but no such effect was observed in the p53 mutants. Where a delay occurred, it was roughly proportional to the X-ray dose. Although it remains to be clarified, whether the cells were delayed only in G1 or also in G0, it is interesting to note that entry into S-phase can be delayed by irradiation in a quiescent state immediately before serum-stimulation, provided the cells are wild-type with respect to p53. Certain differences in the cell cycle response of transformed and untransformed cells were noted.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539453     DOI: 10.1016/0167-8140(95)01618-q

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Influence of irradiation and pentoxifylline on histone H3 phosphorylation in human tumour cell lines.

Authors:  A Binder; L Bohm
Journal:  Cell Prolif       Date:  2002-02       Impact factor: 6.831

2.  Enhancement of phototoxicity of curcumin in human oral cancer cells using silica nanoparticles as delivery vehicle.

Authors:  Surya Prakash Singh; Mrinalini Sharma; Pradeep Kumar Gupta
Journal:  Lasers Med Sci       Date:  2013-06-27       Impact factor: 3.161

3.  [Predictive and prognostic significance of PCNA, p53, bcl-2 and intratumor vessel density in radiochemotherapy of advanced head and neck tumors].

Authors:  G G Grabenbauer
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

4.  G2-block after irradiation of cells with different p53 status.

Authors:  Friedo Zölzer; Ganesh Jagetia; Christian Streffer
Journal:  Strahlenther Onkol       Date:  2014-06-14       Impact factor: 3.621

5.  Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin.

Authors:  Anfernee Kai-Wing Tse; Hui-Hui Cao; Chi-Yan Cheng; Hiu-Yee Kwan; Hua Yu; Wang-Fun Fong; Zhi-Ling Yu
Journal:  J Invest Dermatol       Date:  2013-11-08       Impact factor: 8.551

6.  Hyperthermia induced NFkappaB mediated apoptosis in normal human monocytes.

Authors:  Natarajan Aravindan; Karthigayan Shanmugasundaram; Mohan Natarajan
Journal:  Mol Cell Biochem       Date:  2009-02-15       Impact factor: 3.396

7.  Inhibition of Human Cervical Cancer Cell Growth by Ethanolic Extract of Boerhaavia diffusa Linn. (Punarnava) Root.

Authors:  Rakhi Srivastava; Daman Saluja; Bilikere S Dwarakanath; Madhu Chopra
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-02       Impact factor: 2.629

8.  Differential S-phase progression after irradiation of p53 functional versus non-functional tumour cells.

Authors:  Friedo Zölzer; Tamare Mußfeldt; Christian Streffer
Journal:  Radiol Oncol       Date:  2014-11-05       Impact factor: 2.991

9.  Radiosensitivity of human tumour cells is correlated with the induction but not with the repair of DNA double-strand breaks.

Authors:  R A El-Awady; E Dikomey; J Dahm-Daphi
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.